Question 1

Does Wells Fargo own BTAIQ stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Wells Fargo holds 4,337 shares of BTAIQ (BioXcel Therapeutics), worth $6,115.

Question 2

How many shares of BTAIQ does Wells Fargo own?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo holds 4,337 shares of BTAIQ (BioXcel Therapeutics).

Question 3

What is Wells Fargo's BTAIQ position worth?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo's BTAIQ position is worth $6,115.

Question 4

Is Wells Fargo buying or selling BTAIQ?

Accepted Answer

In Q2 2026, Wells Fargo increased its BTAIQ position by 18 shares (+0.4%).

Question 5

When did Wells Fargo first buy BTAIQ?

Accepted Answer

Wells Fargo already held BTAIQ in its Q1 2025 13F, the earliest on record, and has listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	4,337	+0.4%	$6,115	0.0%	$1.41	11
2026-Q1	Decreased	4,319	-0.1%	$5,787	0.0%	$1.34	0
2025-Q4	Decreased	4,325	-73.5%	$6,920	0.0%	$1.60	0
2025-Q3	Decreased	16,316	-3.6%	$41,769	0.0%	$2.56	0
2025-Q2	Increased	16,919	+37.6%	$30,623	0.0%	$1.81	17
2025-Q1	New	12,293	-	$24,955	0.0%	$2.03	29

BTAIQ6 quarters

BTAIQ
6 quarters